1. 205PA prospective, multicentre, randomized trial comparing vascular access strategies for patients receiving non-trastuzumab containing chemotherapy for early stage breast cancer. (13th May 2019) Authors: Awan, A A; Basulaiman, B; Robinson, A; Stober, C; Fergusson, D; Joy, A A; Vandermeer, L; Mallick, R; Saunders, D; Clemons, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 211PA cost-utility analysis of administration schedules of G-CSF for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer: Economic evaluation alongside the REaCT-G trial. (13th May 2019) Authors: Basulaiman, B; Awan, A A; Hilton, J; Fergusson, D; Stober, C; Vandermeer, L; Saunders, D; Clemons, M; Thavorn, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗